1. Home
  2. FSUN vs ORKA Comparison

FSUN vs ORKA Comparison

Compare FSUN & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSUN
  • ORKA
  • Stock Information
  • Founded
  • FSUN 1892
  • ORKA 2004
  • Country
  • FSUN United States
  • ORKA United States
  • Employees
  • FSUN N/A
  • ORKA N/A
  • Industry
  • FSUN Major Banks
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • FSUN Finance
  • ORKA Health Care
  • Exchange
  • FSUN Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • FSUN 1.1B
  • ORKA 429.4M
  • IPO Year
  • FSUN N/A
  • ORKA N/A
  • Fundamental
  • Price
  • FSUN $35.98
  • ORKA $9.56
  • Analyst Decision
  • FSUN Buy
  • ORKA Strong Buy
  • Analyst Count
  • FSUN 3
  • ORKA 7
  • Target Price
  • FSUN $49.00
  • ORKA $39.67
  • AVG Volume (30 Days)
  • FSUN 121.0K
  • ORKA 221.2K
  • Earning Date
  • FSUN 01-27-2025
  • ORKA 03-06-2025
  • Dividend Yield
  • FSUN N/A
  • ORKA N/A
  • EPS Growth
  • FSUN N/A
  • ORKA N/A
  • EPS
  • FSUN 2.69
  • ORKA N/A
  • Revenue
  • FSUN $359,152,000.00
  • ORKA N/A
  • Revenue This Year
  • FSUN $19.02
  • ORKA N/A
  • Revenue Next Year
  • FSUN $8.04
  • ORKA N/A
  • P/E Ratio
  • FSUN $13.44
  • ORKA N/A
  • Revenue Growth
  • FSUN 1.38
  • ORKA N/A
  • 52 Week Low
  • FSUN $33.31
  • ORKA $8.95
  • 52 Week High
  • FSUN $45.32
  • ORKA $53.88
  • Technical
  • Relative Strength Index (RSI)
  • FSUN 27.46
  • ORKA N/A
  • Support Level
  • FSUN $37.88
  • ORKA N/A
  • Resistance Level
  • FSUN $39.99
  • ORKA N/A
  • Average True Range (ATR)
  • FSUN 1.29
  • ORKA 0.00
  • MACD
  • FSUN -0.14
  • ORKA 0.00
  • Stochastic Oscillator
  • FSUN 4.30
  • ORKA 0.00

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: